Literature DB >> 22305562

Hematopoiesis: a human perspective.

Sergei Doulatov1, Faiyaz Notta, Elisa Laurenti, John E Dick.   

Abstract

Despite its complexity, blood is probably the best understood developmental system, largely due to seminal experimentation in the mouse. Clinically, hematopoietic stem cell (HSC) transplantation represents the most widely deployed regenerative therapy, but human HSCs have only been characterized relatively recently. The discovery that immune-deficient mice could be engrafted with human cells provided a powerful approach for studying HSCs. We highlight 2 decades of studies focusing on isolation and molecular regulation of human HSCs, therapeutic applications, and early lineage commitment steps, and compare mouse and humanized models to identify both conserved and species-specific mechanisms that will aid future preclinical research.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22305562     DOI: 10.1016/j.stem.2012.01.006

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  311 in total

1.  Drosha cuts the tethers of myelopoiesis.

Authors:  Annemarthe G van der Veen; Pierre V Maillard; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2015-11       Impact factor: 25.606

Review 2.  Exploiting genomics and natural genetic variation to decode macrophage enhancers.

Authors:  Casey E Romanoski; Verena M Link; Sven Heinz; Christopher K Glass
Journal:  Trends Immunol       Date:  2015-08-19       Impact factor: 16.687

Review 3.  Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets.

Authors:  Xiuli Sim; Mortimer Poncz; Paul Gadue; Deborah L French
Journal:  Blood       Date:  2016-01-19       Impact factor: 22.113

4.  Quantitative stability of hematopoietic stem and progenitor cell clonal output in rhesus macaques receiving transplants.

Authors:  Samson J Koelle; Diego A Espinoza; Chuanfeng Wu; Jason Xu; Rong Lu; Brian Li; Robert E Donahue; Cynthia E Dunbar
Journal:  Blood       Date:  2017-01-13       Impact factor: 22.113

Review 5.  Hematopoietic stem cells for cancer immunotherapy.

Authors:  Eric Gschweng; Satiro De Oliveira; Donald B Kohn
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 6.  Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies.

Authors:  Robert L Bowman; Lambert Busque; Ross L Levine
Journal:  Cell Stem Cell       Date:  2018-02-01       Impact factor: 24.633

Review 7.  Erythropoiesis, EPO, macrophages, and bone.

Authors:  Joshua T Eggold; Erinn B Rankin
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

8.  Ribosome Levels Selectively Regulate Translation and Lineage Commitment in Human Hematopoiesis.

Authors:  Rajiv K Khajuria; Mathias Munschauer; Jacob C Ulirsch; Claudia Fiorini; Leif S Ludwig; Sean K McFarland; Nour J Abdulhay; Harrison Specht; Hasmik Keshishian; D R Mani; Marko Jovanovic; Steven R Ellis; Charles P Fulco; Jesse M Engreitz; Sabina Schütz; John Lian; Karen W Gripp; Olga K Weinberg; Geraldine S Pinkus; Lee Gehrke; Aviv Regev; Eric S Lander; Hanna T Gazda; Winston Y Lee; Vikram G Panse; Steven A Carr; Vijay G Sankaran
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

Review 9.  Mouse models in bone marrow transplantation and adoptive cellular therapy.

Authors:  Caroline Arber; Malcolm K Brenner; Pavan Reddy
Journal:  Semin Hematol       Date:  2013-06-11       Impact factor: 3.851

10.  Accumulation of mtDNA variations in human single CD34+ cells from maternally related individuals: effects of aging and family genetic background.

Authors:  Yong-Gang Yao; Sachiko Kajigaya; Xingmin Feng; Leigh Samsel; J Philip McCoy; Giuseppe Torelli; Neal S Young
Journal:  Stem Cell Res       Date:  2013-01-29       Impact factor: 2.020

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.